Uralyt-u

Citric acid, potassium citrate, sodium citrate

Combination product

This product contains more than one active ingredient, so it has no single molecular structure.

Registration

Applicants: 1
Registrations: 1

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
Viatris South Africa (Pty) Ltd	Uralyt-u	2,5 g	H1773	Not determined	PI PIL

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Uralyt-u EACH 100,0 g GRANULES CONTAIN CITRIC ACID 13,044 g POTASSIUM CITRATE 45,397 g SODIUM CITRATE 41,153 g	2,5 gGranules	H1773H/18.4/01773Approved 28 March 2024	Registered	Not determined	PI PIL

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

Background

Loading Wikipedia summary

SAHPRA documents

Professional information (PI)For healthcare professionalsUralyt-u, Viatris South Africa (Pty) Ltd Patient information leaflet (PIL)For patients and carersUralyt-u, Viatris South Africa (Pty) Ltd

These documents come from SAHPRA's PI-PIL repository unless the line under a document says otherwise. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles